Open access · CC-BY
via OpenAlex
Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence
Lijuan Gao, Yongsheng Qin, Yudai Xu, Ju Su, Zhicheng Cai, Zhongyu Hu, Ruohu Shi, Xinyi Mu, Shiying Cen, Chanchan Xiao, Guobing Chen
Frontiers in Aging · 2026
Abstract
The intensifying global population aging has rendered the development of anti-aging drugs a core challenge in the life sciences domain. Traditional models struggle to address the systemic and networked nature of aging. Multi-omics technologies provide a panoramic perspective for deciphering molecular networks of aging, while Artificial Intelligence (AI) has demonstrated significant advantages in target discovery, drug screening, and clinical trial optimization. This review systematically elaborates on the pathological characteristics and molecular mechanisms of aging, analyzes the application paradigms of multi-omics in biomarker screening, mechanism elucidation, and high-throughput screening, and discusses the core value and technical bottlenecks of AI in target prediction, virtual screening, and trial design. Simultaneously, this paper addresses critical challenges including ethical controversies and data standardization currently confronting the field, and explores the prospects of precision anti-aging drug development and personalized treatment strategies driven by deep integration of multi-omics and AI. This approach offers novel theoretical frameworks and practical pathways for extending human healthspan(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fragi.2026.1868486
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Gao, L., Qin, Y., Xu, Y., Su, J., Cai, Z., Hu, Z., Shi, R., Mu, X., Cen, S., Xiao, C., & Chen, G. (2026). Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence. <em>Frontiers in Aging</em>. https://doi.org/10.3389/fragi.2026.1868486
Vancouver
Gao L, Qin Y, Xu Y, Su J, Cai Z, Hu Z, et al. Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence. Frontiers in Aging. 2026. doi:10.3389/fragi.2026.1868486.
BibTeX
@article{lijuan2026Advanc,
title = {Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence},
author = {Lijuan Gao and Yongsheng Qin and Yudai Xu and Ju Su and Zhicheng Cai and Zhongyu Hu and Ruohu Shi and Xinyi Mu and Shiying Cen and Chanchan Xiao and Guobing Chen},
journal = {Frontiers in Aging},
year = {2026},
doi = {10.3389/fragi.2026.1868486},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in aging 2026
Open access · OA
Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence.
Advances in biogerontology 2026
Citation only
Current advances in drug discovery for aging
2019
Citation only
Transcriptomic Profiling of Nasal Epithelial Brushings Identifies Signatures of Aging
Frontiers in Genetics 2022
Open access · CC-BY
The Utility of Small Fishes for the Genetic Study of Human Age-Related Disorders
Cell 2023
Open access · OA
Distinct longevity mechanisms across and within species and their association with aging
Springer eBooks 2005
Citation only